Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis
7.5
来源：
Nature
关键字：
TCR-T
发布时间：
2025-11-07 07:46
摘要：
Takayasu arteritis (TAK) is a rare, chronic large-vessel vasculitis primarily affecting young women. The article highlights advances in understanding its pathophysiology, diagnosis, and treatment. Key developments include the identification of genetic susceptibility loci, the importance of non-invasive imaging for diagnosis, and the evolving role of biologic agents in treatment, particularly for refractory cases. The article serves as a comprehensive resource for clinicians and researchers aiming to improve management strategies for this complex disease.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
0.5
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.0
market_value_relevance
1.0
team_institution_background
0.0
technical_barrier_competition
0.0
关键证据
Takayasu arteritis is a rare large-vessel vasculitis with a global incidence of 1.11 per million person-years.
The management of TAK is evolving, driven by an improved understanding of disease pathogenesis.
The growing use of biologic agents is providing new treatment options, particularly for patients with refractory or relapsing disease.
真实性检查
否
AI评分总结
Takayasu arteritis (TAK) is a rare, chronic large-vessel vasculitis primarily affecting young women. The article highlights advances in understanding its pathophysiology, diagnosis, and treatment. Key developments include the identification of genetic susceptibility loci, the importance of non-invasive imaging for diagnosis, and the evolving role of biologic agents in treatment, particularly for refractory cases. The article serves as a comprehensive resource for clinicians and researchers aiming to improve management strategies for this complex disease.